by rss feed | Sep 20, 2026 | Longeveron, News Feeds, weekly reads, XPRIZE Healthspan
Longeveron is a biotech focused on mesenchymal stromal/stem cells or MSCs. Its big news this year was a report in Cell Stem Cell about a potential benefit for frailty from its product laromestrocel. I’ll talk more about that and my concerns further down. Now...
by rss feed | Sep 13, 2026 | IPS cells, News Feeds, Reprogramming, weekly reads
Do you buy the idea of using in vivo reprogramming to fight aging? How about to treat certain diseases? The stream of research pubs and news articles continues to grow. Before we jump into weekly reads including on reprogramming applications, on the 20th anniversary...
by rss feed | Sep 6, 2026 | GHK-Cu, News Feeds, Peptides, weekly reads
Anyone out there use a peptide cream? You might not even know it. I just saw by chance that one of the family uses a shampoo that says “peptides” on it. If you search on Amazon for “peptide cream” you get about an infinite number of results....
by rss feed | May 16, 2021 | cancer stem cells, News Feeds, pluripotent stem cells, weekly reads
This was a busy week for me working on a grant due Friday and a bunch of other stuff including happily analyzing a bunch of data, but there were tons of interesting papers recently including on pluripotency. California stem cell clinic court case on in the background...
by rss feed | May 9, 2021 | Histones, News Feeds, Oncodevelopmental biology, oncogenes, weekly reads
One of my main research interests is in oncodevelopmental factors. These include factors that are important both for normal stem cell biology and development as well as driving cancer when misregulated. One example includes the MYC family of proto-oncogenes. When I...
by rss feed | Apr 18, 2021 | celularity, Fetal tissue, News Feeds, Stem Cell News, weekly reads
It’s been a week with a wide variety of regenerative medicine papers and stem cell news. Here’s my earlier take from a few days ago on the Belmonte-led human-monkey chimeric embryo paper in Cell that broke this week. A few days ago I also put up a new...